Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Tokyo  >  Terumo Corp    4543   JP3546800008

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Terumo : Expands Production in Asia New Factory Established and Existing Facilities Expanded in Vietnam and the Philippines

share with twitter share with LinkedIn share with facebook
share via e-mail
0
05/10/2012 | 08:13am CEST
May 10, 2012

Terumo Corporation (TOKYO:4543) announced today that it will expand its production facilities in Asia to meet anticipated sales increases in the medium to long term, based on its corporate growth strategy. Terumo Corporation will establish a new factory in Vietnam, its second in the country, as well as expand the production scale of existing factories in Vietnam and the Philippines. The total amount invested will be 15 billion yen.

The new factory in Vietnam will produce blood management products such as blood bags to meet growing global demand, especially in emerging countries.
In cooperation with Ashitaka factory (Shizuoka prefecture) and the new Yamaguchi factory in Japan (operation to be started in 2015), the existing factory in Vietnam will expand the production scale of interventional systems products, sales of which have been growing at a double-digit pace. The company will also establish a new production building at the existing factory in the Philippines to cope with needed production increases of syringes and needles.
To improve its global competitiveness, Terumo Corporation is seeking to enhance the production capacity across all of its three business areas: Cardiac & Vascular, General Hospital, and Blood Management.

Terumo Corporation's global production system

Terumo Corporation is accelerating its growth globally, and plans to increase the percent of production done outside Japan in line with the growth in the share of net sales outside Japan, which already account for over half of the total. Accordingly, the company has positioned factories in Asia as its global production center and is already producing a broad range of products in China, the Philippines, and Vietnam.
On another front, certain highly advanced and precise production technologies are difficult to transfer outside of Japan. The company has designated factories in Japan as mother production factories that develop and refine core manufacturing technologies to underpin product improvement.
Terumo Corporation will continue to enhance its global production system in factories in Asia and Japan to meet growing global demand while increasing cost competitiveness.

Factories Overview 1. Vietnam: a new factory to be established

In April 2012, Terumo BCT was established through the integration of CaridianBCT and Terumo Transfusion, following Terumo Corporation's acquisition of CaridianBCT in April 2011. The company will establish a new factory in Vietnam to produce blood management products to meet growing global demand, especially in emerging countries. The factory will be its sixth production facilities of blood management products, following ones in Japan, U.S., UK

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on TERUMO CORP
09/14 TERUMO : Federal Contracts Awarded by Federal Agencies in Massachusetts (Sept. 1..
09/14 TERUMO : MicroVention Assigned Patent
09/13 TERUMO : MILITARY $444,283 Federal Contract Awarded to Microvention
09/02 TERUMO : JICA invests in Ghana’s health sector
09/01 TERUMO : JICA supports Ghana to make blood safer
08/31 GLOBAL DISPOSABLE SYRINGES MARKET 20 : Feel Tech, Terumo, Brad, EXEL, Gerresheim..
08/25 TERUMO : MILITARY $60,720 Federal Contract Awarded to Terumo BCT
08/25 TERUMO : Notice Concerning the Determination of Details of Issuance of Stock Opt..
08/17 TERUMO : MicroVention Assigned Patent
08/10 TERUMO : MicroVention Assigned Patent
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
09/17DJJ&J to Buy Abbott Eye Business -- WSJ
09/16DJJ&J to Buy Abbott's Eye-Surgery Unit for $4.325 billion -- 2nd Update
09/16DJJ&J to Buy Abbott's Eye-Surgery Unit for $4.325 billion -- 3rd Update
09/16DJJ&J to Buy Abbott's Eye-Surgery Unit for $4.325 billion -- Update
09/16DJJ&J Nears Deal to buy Abbott's Eye-Surgery Equipment Unit
More sector news : Medical Equipment, Supplies & Distribution - NEC
Advertisement
Financials ( JPY)
Sales 2017 506 812 M
EBIT 2017 -
Net income 2017 51 569 M
Debt 2017 31 288 M
Yield 2017 1,04%
P/E ratio 2017 28,33
P/E ratio 2018 26,06
EV / Sales 2017 3,07x
EV / Sales 2018 2,84x
Capitalization 1 522 840 M
More Financials
Chart TERUMO CORP
Duration : Period :
Terumo Corp Technical Analysis Chart | 4543 | JP3546800008 | 4-Traders
Full-screen chart
Technical analysis trends TERUMO CORP
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 16
Average target price 4 413  JPY
Spread / Average Target 10%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Yutaro Shintaku President & Representative Director
Ryo Nishihata Chief Accounting & Financial Officer, IR Contact
Hiroaki Kasukawa CTO, Executive Officer, GM-Research & Development
Katsuya Takeuchi Executive Officer & Chief Information Officer
Takayoshi Mimura Director & Senior Managing Executive Officer
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
TERUMO CORP8.09%15 064
MEDTRONIC PLC14.03%121 210
BAXTER INTERNATIONAL I..24.48%25 829
ZIMMER BIOMET HOLDINGS..25.09%25 668
C R BARD INC21.36%16 888
SYSMEX CORP-2.82%15 655
More Results